Lv1
40 积分 2023-06-25 加入
P2 Purinergic Receptors in Tumor Immunity
11天前
已完结
The causal effects of inflammatory bowel disease on primary biliary cholangitis: A bidirectional two‐sample Mendelian randomization study
16天前
已完结
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy
1个月前
已完结
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients
1个月前
已完结
Single-cell analysis of the human immune system reveals sex-specific dynamics of immunosenescence
1个月前
已完结
Is Liver Resection Still Required for Patients Who Have Predictive Factors for Complete Pathologic Necrosis after Downstaging Treatments of Locally Advanced Hepatocellular Carcinoma?
1个月前
已完结
Combination of programmed death protein-1 inhibitor improves the efficacy of transarterial chemoembolization plus lenvatinib for unresectable intermediate-stage hepatocellular carcinoma: a real-world multi-center retrospective study
1个月前
已完结
Prognosis predictors of hepatocellular carcinoma after hepatectomy following conversion therapy
1个月前
已完结
Online risk scores for pre- and postoperative prediction of early recurrence in hepatocellular carcinoma patients undergoing conversion liver resection after tyrosine kinase inhibitors and immune checkpoint inhibitors therapy
1个月前
已完结
Conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: A comparative analysis in a real-world cohort
1个月前
已完结
皖公网安备34019202002308
